Abstract
This letter summarizes recommendations from the interdisciplinary working group of renal tumors (IAGN) of the German Cancer Society for the systemic treatment of advanced/metastatic renal cell carcinoma in the context of the current SARS-CoV-2 pandemic.
MeSH terms
-
Antineoplastic Agents* / therapeutic use
-
Betacoronavirus
-
COVID-19
-
Carcinoma, Renal Cell* / drug therapy
-
Coronavirus Infections*
-
Humans
-
Kidney Neoplasms* / drug therapy
-
Pandemics*
-
Pneumonia, Viral*
-
Practice Guidelines as Topic
-
SARS-CoV-2